Читать книгу - "Живи долго! Научный подход к долгой молодости и здоровью - Майкл Грегер"

2011;3(3):370–84. https://pubmed.ncbi.nlm.nih.gov/22254102/

678

Bailey SW, Ayling JE. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc Natl Acad Sci U S A. 2009;106(36):15424–9. https://pubmed.ncbi.nlm.nih.gov/19706381/

679

Selhub J, Rosenberg IH. Excessive folic acid intake and relation to adverse health outcome. Biochimie. 2016;126:71–8. https://pubmed.ncbi.nlm.nih.gov/27131640/

680

Troen AM, Mitchell B, Sorensen B, et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr. 2006;136(1):189–94. https://pubmed.ncbi.nlm.nih.gov/16365081/

681

Bo Y, Zhu Y, Tao Y, et al. Association between folate and health outcomes: an umbrella review of meta-analyses. Front Public Health. 2020;8:550753. https://pubmed.ncbi.nlm.nih.gov/33384976/

682

U.S. Preventive Services Task Force. Final recommendation statement: folic acid for the prevention of neural tube defects: preventive medication. U.S. Preventive Services Task Force. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication. Published January 10, 2017. Accessed May 26, 2021.; https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication

683

Dudeja PK, Torania SA, Said HM. Evidence for the existence of a carrier-mediated folate uptake mechanism in human colonic luminal membranes. Am J Physiol. 1997;272(6Pt1):G1408–15. https://pubmed.ncbi.nlm.nih.gov/9227476/

684

Strozzi GP, Mogna L. Quantification of folic acid in human feces after administration of Bifidobacterium probiotic strains. J Clin Gastroenterol. 2008;42 Suppl 3 Pt 2:S179–84. https://pubmed.ncbi.nlm.nih.gov/18685499/

685

Rando TA, Chang HY. Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell. 2012;148(1–2):46–57. https://pubmed.ncbi.nlm.nih.gov/22265401/

686

Hellwig M, Henle T. Baking, ageing, diabetes: a short history of the Maillard reaction. Angew Chem Int Ed. 2014;53(39):10316–29. https://pubmed.ncbi.nlm.nih.gov/25044982/

687

Teodorowicz M, Hendriks WH, Wichers HJ, Savelkoul HFJ. Immunomodulation by processed animal feed: the role of Maillard reaction products and advanced glycation end-products (AGEs). Front Immunol. 2018;9:2088. https://pubmed.ncbi.nlm.nih.gov/30271411/

688

Sadowska-Bartosz I, Bartosz G. Effect of glycation inhibitors on aging and age-related diseases. Mech Ageing Dev. 2016;160:1–18. https://pubmed.ncbi.nlm.nih.gov/27671971/

689

Unnikrishnan R, Anjana RM, Mohan V. Drugs affecting HbA1c levels. Indian J Endocrinol Metab. 2012;16(4):528–31. https://pubmed.ncbi.nlm.nih.gov/22837911/

690

American Diabetes Association. Understanding A1C. American Diabetes Association website. https://www.diabetes.org/a1c. Accessed June 2, 2021.; https://www.diabetes.org/a1c

691

Sadowska-Bartosz I, Bartosz G. Effect of glycation inhibitors on aging and age-related diseases. Mech Ageing Dev. 2016;160:1–18. https://pubmed.ncbi.nlm.nih.gov/27671971/

692

Verzijl N, DeGroot J, Thorpe SR, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem. 2000;275(50):39027–31. https://pubmed.ncbi.nlm.nih.gov/10976109/

693

Fedintsev A, Moskalev A. Stochastic non-enzymatic modification of long-lived macromolecules – a missing hallmark of aging. Ageing Res Rev. 2020;62:101097. https://pubmed.ncbi.nlm.nih.gov/32540391/

694

Green AS. mTOR, glycotoxins and the parallel universe. Aging (Albany NY). 2018;10(12):3654–6. https://pubmed.ncbi.nlm.nih.gov/30540565/

695

Bettiga A, Fiorio F, Di Marco F, et al. The modern Western diet rich in advanced glycation end-products (AGES): an overview of its impact on obesity and early progression of renal pathology. Nutrients. 2019;11(8):1748. https://pubmed.ncbi.nlm.nih.gov/31366015/

696

Garay-Sevilla ME, Beeri MS, de la Maza MP, Rojas A, Salazar-Villanea S, Uribarri J. The potential role of dietary advanced glycation endproducts in the development of chronic non-infectious diseases: a narrative review. Nutr Res Rev. 2020;33(2):298–311. https://pubmed.ncbi.nlm.nih.gov/32238213/

697

Chen JH, Lin X, Bu C, Zhang X. Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies. Nutr Metab (Lond). 2018;15(1):72. https://pubmed.ncbi.nlm.nih.gov/30337945/

698

Prasad C, Davis KE, Imrhan V, Juma S, Vijayagopal P. Advanced glycation end products and risks for chronic diseases: intervening through lifestyle modification. Am J Lifestyle Med. 2019;13(4):384–404. https://pubmed.ncbi.nlm.nih.gov/31285723/

699

Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci. 2010;65A(9):963–75. https://pubmed.ncbi.nlm.nih.gov/20478906/

700

Green AS. mTOR, glycotoxins and the parallel universe. Aging (Albany NY). 2018;10(12):3654–6. https://pubmed.ncbi.nlm.nih.gov/30540565/

701

Sergi D, Boulestin H, Campbell FM, Williams LM. The role of dietary advanced glycation end products in metabolic dysfunction. Mol Nutr Food Res. 2021;65(1):1900934. https://pubmed.ncbi.nlm.nih.gov/32246887/

702

Sadowska-Bartosz I, Bartosz G. Effect of glycation inhibitors on aging and age-related diseases. Mech Ageing Dev. 2016;160:1–18. https://pubmed.ncbi.nlm.nih.gov/27671971/

703

. Šebeková K, Brouder Šebeková K. Glycated proteins in nutrition: friend or foe? Exp Gerontol. 2019;117:76–90. https://pubmed.ncbi.nlm.nih.gov/30458224/

704

Fedintsev A, Moskalev A. Stochastic non-enzymatic modification of long-lived macromolecules – a missing hallmark of aging. Ageing Res Rev. 2020;62:101097. https://pubmed.ncbi.nlm.nih.gov/32540391/

705

Azman KF, Zakaria R. D-galactose-induced accelerated aging model: an overview. Biogerontology. 2019;20(6):763–82. https://pubmed.ncbi.nlm.nih.gov/31538262/

706

Sadowska-Bartosz I, Bartosz G. Effect of glycation inhibitors on aging and age-related diseases. Mech Ageing Dev. 2016;160:1–18. https://pubmed.ncbi.nlm.nih.gov/27671971/

707

Fedintsev A, Moskalev A. Stochastic non-enzymatic modification of long-lived macromolecules – a missing hallmark of aging. Ageing Res Rev. 2020;62:101097. https://pubmed.ncbi.nlm.nih.gov/32540391/

708

Teissier T, Boulanger É. The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging. Biogerontology. 2019;20(3):279–301. https://pubmed.ncbi.nlm.nih.gov/30968282/

709

Green AS. mTOR, glycotoxins and the parallel universe. Aging (Albany NY). 2018;10(12):3654–6. https://pubmed.ncbi.nlm.nih.gov/30540565/

710

Teissier T, Boulanger É. The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging. Biogerontology. 2019;20(3):279–301. https://pubmed.ncbi.nlm.nih.gov/30968282/

711

Gill V, Kumar V, Singh K, Kumar A, Kim JJ. Advanced glycation end products (AGEs) may be a striking link between